Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenAlex
Works that cite this article, indexed by OpenAlex.
Antiviral peptides as promising therapeutic drugs
Cellular and Molecular Life Sciences 76(18) (2019)
Liana Costa Pereira Vilas Boas; Marcelo Lattarulo Campos; Rhayfa Lorrayne Araújo Berlanda; Natan de Carvalho Neves; Octávio Luiz Franco
National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care
Journal of Viral Hepatitis 24(4) (2017)
Wafaa Elakel; Manal Hamdy El-Sayed; Mohamed El‐Kassas; Magdy El‐Serafy; Marwa Khairy; Kadry Elsaeed; Khaled Kabil; Mohamed Hassany; A. Shawky; A. Yosry; Mohamed Kamal Shaker; Y. Elshazly; Imam A. Waked; Gamal Esmat; Wahid H. Doss
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
World Journal of Gastroenterology 24(38) (2018)
Dalia Omran; Mohamed Aly Abdelkhalek Alboraie; Rania A. Zayed; Mohamed-Naguib Abdalla Wifi; Mervat Naguib; Mohamed Mahmoud Eltabbakh; Mohamed F. Abd‐Ellah; Ahmed Fouad Sherief; Sahar Maklad; Heba H. El-Demellawy; Omar Khalid Saad; Doaa Mohamed Khamiss; Mohamed El‐Kassas
The current and future disease burden of chronic hepatitis C virus infection in Egypt
Arab Journal of Gastroenterology 15(2) (2014)
Imam A. Waked; Waheed Doss; Manal Hamdy El-Sayed; Chris R. Estes; Homie A. Razavi; Gamal El-Sayed Shiha; Ayman Yosry; Gamal Esmat
ENNAVIA is a novel method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides
Briefings in Bioinformatics 22(6) (2021)
Patrick Brendan Timmons; Chandralal M. Hewage
HCV in Egypt, prevention, treatment and key barriers to elimination
Expert Review of Anti-infective Therapy 16(4) (2018)
Mohamed El‐Kassas; Tamer Mahmoud Elbaz; Aisha Mahmoud Elsharkawy; Heba Omar; Gamal Esmat
Hepatitis C genotype 4: The past, present, and future
World Journal of Hepatology 7(28) (2015)
Tawhida Yassin Abdel-Ghaffar
Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt
Expert Review of Anti-infective Therapy 18(7) (2020)
Gamal Esmat; Tamer Mahmoud Elbaz; Aisha Mahmoud Elsharkawy; Mohamed Abdullah; Mohamed El‐Kassas
Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C
Cochrane Database of Systematic Reviews 2014(2) (2014)
Goran Hauser; Tahany Awad; Kristian Thorlund; Davor Štimac; Mahasen Mabrouk; Christian Nyfeldt Gluud
Management of hepatitis C genotype 4 in the directly acting antivirals era
BMJ Open Gastroenterology 3(1) (2016)
Emma Hathorn; Ahmed Mohamed Elsharkawy
Optimizing treatment for HCV genotype 4: PEG‐IFN alfa 2a vs. PEG‐IFN alfa 2b; the debate continues
Liver International 34(s1) (2013)
Gamal Esmat; Mohamed El‐Kassas; Mohamed Hassany; Mohamed Gamil; Maissa El Raziky
Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis
BMJ Open Gastroenterology 2(1) (2015)
Brittany E. Yee; Nghia H. Nguyen; Bing Zhang; Derek Lin; Philip Vutien; Carrie R. Wong; Glen A. Lutchman; Mindie H. Nguyen
Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing Regimens
Journal of Interferon & Cytokine Research 38(3) (2018)
Maissa El Raziky; Marwa Khairy; Ahmed Fouad; Ahmed Salama; Aisha Mahmoud Elsharkawy; Omnia Tantawi
Real-life results of sofosbuvir based therapy in chronic hepatitis C -naïve and -experienced patients in Egypt
PLoS ONE 12(10) (2017)
Ahmed Nagaty; Ekram Wassim Abd El-Wahab
Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4
Clinical Interventions in Aging 11 (2016)
Sami A. Gabr; Ahmad H. Alghadir; Ahmed A. Allam; Jamaan Said Ajarem; Ghada Al-Basher; Mostafa A. Abdel-Maksoud; Ayman A. Ghfar; Alaa Aboud
Serum MicroRNAs as predictors for fibrosis progression and response to direct‐acting antivirals treatment in hepatitis C virus genotype‐4 Egyptian patients
International Journal of Clinical Practice 75(4) (2020)
Rasha M. M. Khairy; Safaa Said Hmmad; Mohammed A. Sayed; Hazem Abdel Wahab Ahmed; Mona Esmail
Direct-acting antiviral regimens in Egyptian patients with chronic hepatitis C virus infection: A real-world single-center experience
Arab Journal of Gastroenterology 22(4) (2021)
Gina Gamal Naguib; Amir Farid; Mohamed Said Hassan; Ahmed I. Elshafie; Yehia El Shazly; Mohamed Kamal Shaker; Haitham Ezzat; Eslam Safwat; Ossama Ashraf Ahmed; Hany Mansour Dabbous; Ahmed Fouad Sherief; Mohamed Hassany; Magdy El‐Serafy; Manal Hamdy El-Sayed
Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C
Hepatitis Monthly 15(9) (2015)
Mahdiyar Pouresmaeeli; Seyed Moayed Alavian; Maryam Keshvari; Shima Salimi; Leila Mehrnoush
Meta-analysis
European Journal of Gastroenterology & Hepatology 26(11) (2014)
Brittany E. Yee; Nghia H. Nguyen; Bing Zhang; Philip Vutien; Carrie R. Wong; Glen A. Lutchman; Mindie H. Nguyen
A Real Life Study on Treatment of Egyptian Patients with HCV Genotype IV with Simeprevir and Sofosbuvir
Health 08(09) (2016)
Abdelfattah Hanno; Doaa Ahmed Elwazzan; Munjed M. Ibrahim; Rania Mohamed Mahmoud Hafez
A comparative study of variants of pegylated interferon alpha in treatment of chronic HCV patients
Apmis 123(6) (2015)
Dalia El Sabaawy; Sahar M. El-Haggar; Hoda A. El‐Bahrawy; Imam A. Waked; Hala El‐Said
Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy
Journal of Interferon & Cytokine Research 36(3) (2016)
Gamal Esmat; Wafaa Elakel; Rasha Abdelaziz; Ahmed Taha; Dina Sabry; Laila Ahmed Rashed; Aya Mostafa; Amany Y. Elkazaz; Sahar H. Ahmed
Characterization of demographics and NS 5A genetic diversity for hepatitis C virus genotype 4‐infected patients with or without cirrhosis treated with ombitasvir/paritaprevir/ritonavir
Journal of Viral Hepatitis 25(9) (2018)
Gretja Schnell; Rakesh L. Tripathi; Jill M. Beyer; T. Reisch; Preethi Krishnan; Tatyana Dekhtyar; Michelle Irvin; Coleen M. Hall; Yao Yu; Niloufar Mobashery; R. Redman; T. Pilot‐Matias; C. Collins
Genotype 4 hepatitis C virus-a review of a diverse genotype
Advances in Medical Sciences 68(1) (2023)
Michał Brzdęk; Krystyna Dobrowolska; Robert Flisiak; Dorota Zarębska‐Michaluk
Establishing a research production line in real-life settings: the case of Hepatitis C management in a viral hepatitis specialized Egyptian center
Current Medical Research and Opinion 38(4) (2022)
Mohamed El‐Kassas; Mohamed Mahmoud Eltabbakh; Mohamed Elbadry; Ahmed Tawheed; Tamer Mahmoud Elbaz
Forecasted impacts of a sofosbuvir-based national hepatitis C treatment programme on Egypt’s hepatocellular cancer epidemic: simulation of alternatives
BMJ Global Health 3(2) (2018)
Wenkang Ma; Amr S. Soliman; Wagida A. Anwar; Ahmed Hablas; Tamer B El Din; Mohamed Ramadan; Ibrahim A. Seifeldin; Mark L. Wilson
Hepatitis C Virus in Thalassemia
InTech eBooks (2018)
Mohamed Ramadan El-Shanshory; M Awad; Hanan Hamed Soliman
The Efficacy of a Hansenula -Derived 20 kDa Pegylated Interferon Alpha-2a in the Treatment of Genotype 4 Chronic Hepatitis C
Journal of Interferon & Cytokine Research 34(9) (2014)
Hany M. Shehab; Tamer Mahmoud Elbaz; Dalia M. Deraz; Amal Hafez; Inas Anwar Elattar
Assessment of efficacy and safety of two Egyptian protocols for treatment-experienced HCV patients: an observational study
The Egyptian Journal of Internal Medicine 34(1) (2022)
Radwa Samir Hagag; Morkoss Fakhry; Ossama Ashraf Ahmed; Shaimaa Abdalaleem Abdalgeleel; Mahasen Ali Radwan; Gina Gamal Naguib
Current issues in comparative effectiveness research for hepatitis C
Comparative Effectiveness Research (2014)
JOSEPH E. BISKUPIAK; Minkyoung Yoo; Yan Cheng; Taylor Rhien
Factors Affecting the Virological Response Among Chronic Hepatitis C Virus Patients in Yemen
Journal of Interferon & Cytokine Research 38(1) (2018)
Zaid Mutahar Mohammed Alezzi; Ayman Yosry; Waleed Fouad Fathalah; Mansour Ali Al-Amrani; Fouad Othman
Molecular Characterization of NS5A Resistance Associated Substitutions after Failure of Sofosbuvir/Daclatasvir Combination Therapy in Chronic Hepatitis C Genotype 4a Infected Egyptian Patients Compared to Direct-Acting Antiviral Agent (DAA)-Naïve Sequences
The Egyptian Journal of Medical Microbiology 27(4) (2018)
Raghdaa A. Ramadan; Ahmed Mohammed; Ahmed Elsadek Fakhr
The outcome of re-treatment of relapsed hepatitis C virus infection in a resource-limited setting
VirusDisease 32(3) (2021)
Gina Gamal Naguib; Tari George Michael; Yehia Elshazly; Maha Magdy Mahmoud Wahdan; Aya Mostafa; Ossama Ashraf Ahmed; Hany Mansour Dabbous; Heba Ismail Saad Aly; Mohamed Kamal Shaker; Hosam S Elbaz; Magdy El‐Serafy; Wahid H. Doss; Sherief Mohamed Abd-Elsalam; Manal Hamdy El-Sayed
Association of vitamin D binding protein polymorphisms with response to therapy in Egyptian chronic hepatitis C patients
The Journal of Infection in Developing Countries 11(10) (2017)
Ahmed Mohamed Kamel; Samar Farghali Farid; Ahmed Sherif Attia; Maissa El Raziky
Antiviral peptidlerin SARS COV-2 ana proteaz yapısına bağlanma etkinliklerinin protein-yanaştırma yöntemi ile incelenmesi: In silico bir çalışma
Frontiers in Life Sciences and Related Technologies 3(3) (2022)
İlter DEMİRHAN; Erkan Öner; Ergül Belge Kurutaş
Thrombocytopenia in Egyptian Patients with Hepatitis C Virus Treated with Standard of Care Therapy: A Cohort Study
International Journal of TROPICAL DISEASE & Health 4(12) (2014)
Eman Medhat; Gamal Esmat; Mohamed Seif; Mohammed El-Beshlawy; Raghda N. Marzaban; Zeinab Zakaria; Fatma Abuliela
Optimal Management of HCV Genotype 4
Current Hepatology Reports 13(4) (2014)
Wael Abdel‐Razek; Imam A. Waked
Role of Interleukin-10, Interleukin-12 in the Response Prediction during Combined PEG Interferon-alpha 2a and Ribavirin Therapy in Patients with Chronic Hepatitis C
Journal of Virology & Antiviral Research 04(01) (2015)
Amal Ahmed Mohamed
The effect of the degree of hepatitis C-related fibrosis on the responsiveness to pegylated interferon α-2a versus pegylated interferon α-2b
Egyptian Liver Journal 6(2) (2016)
Yehia Mohamed El Shazly; Mohamed A. El Bokl; Mohamed Abd EL Moghny Mostafa; Nanees Ahmed Adel; Mohamed Omar Khalifa; Ossama Ashraf Ahmed; Ahmed I. Elshafie; Mohamed Hassan Ahmed Fouad; Gina Gamal Naguib
Pathology Predictors of Response to Combined Therapy of Chronic HCV Patients; Is it Applicable in the DAA Era?
Gastroenterology & Hepatology Open Access 5(8) (2016)
Samar Kamal Darweesh
BENEFIT OF ADDING SOFOSBUVIR TO INTERFERON AND RIBAVIRIN IN RETREATING CHRONIC HEPATITIS C PATIENTS NOT RESPONDING TO INTERFERON AND RIBAVIRIN
Al-Azhar Medical Journal 49(2) (2020)
Mohamed Badry Bastawy; Medhat Elsahhar; Sayed Farouk Mohamed Ahmed; Ahmed Hanafy Ahmed Soliman Khattab
Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals
F1000Research 11 (2022)
Nehal K. Abdel Fattah; Sara M. Shaheen; Osama Ashraf Ahmed; Kadry Elsaeed; Nagwa A. Sabri
Efficacy and Safety of Generic (Velpatasvir containing regimen) among Adult Chronic HCV Patients Non-responders to Treatment by Sofosbuvir Plus Daclatasvir Regimen in Egypt
Delta Journal of Science 46(3) (2023)
Eman Mahmoud Fares; Wessam M. Ragab; Heba A. El‐dash; Naglaa R. Ismael; Ahmed Gomaa
Frequency of Sustained Virologic Response in Hepatitis C Positive, Treatment Naïve Patients on Sofosbuvir and Daclatasvir
Journal of Gandhara Medical and Dental Science 10(3) (2023)
Islam Shah; Nayab Munib; Aliena Badshah; Wazir Mohammad Khan
Effect of sofosbuvir and ribavirin therapy on hearing
The Scientific Journal of Al-Azhar Medical Faculty Girls 4(3) (2020)
Naema M. Ismail; Gamal M El-Serafy; AMAL H. EWIDA; Iman Ibrahim Mohamed Eladawy; Mona Abd-Elmo′men
Serum IL-12p70 and TLR 7 gene expression in Egyptian patients infected with HCV and treated with Sofosbuvir, Ribavirin and/or Pegylated interferon
International Journal of Biosciences (IJB) (2017)
Hala M. Aldesouki, Hanan M. Zidan, Eman M. Elashry